Evaluation of Antidiabetic Drug Prescription Trends in a Tertiary Care Hospital's Outpatient Department

Background: The main goal of treatment for preventing damage to target organs and other problems from diabetes is still glucose control. When diabetes mellitus is present, poor glycemic control can be avoided with the prudent use of oral hypoglycemic medications (OHA). Drug utilization studies are a useful tool for assessing the rational use of medications in populations. Approach: Prior to starting the trial, the Institutional Ethics Committee’s necessary approval was acquired. After obtaining agreement, 300 Type II diabetes mellitus patients who met the study’s specific inclusion and exclusion criteria were added to the trial. These patients were given a case record form that included information about their sociodemographic profile and prescription pattern. The majority of patients (65%) were receiving combination therapy, while 35% were receiving antidiabetic monotherapy. Biguanides made up 50% of all prescribed medications, followed by sulfonylureas (26%), DPP4 inhibitors (21%), and OHA combination therapy. The most commonly prescribed medication was metformin (80%), followed by sulfonylureas (45%) and DPP4 inhibitors Teneligliptin (18%), Vildagliptin (15%). Conclusion: Metformin was the most commonly prescribed medication in diabetes.